Stockreport

Arcus Biosciences up 84% on rumored Gilead interest [Seeking Alpha]

Arcus Biosciences, Inc.  (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report
PDF Thinly traded cancer therapy developer Arcus Biosciences (RCUS+83.7%reportsGILD+2.0%The company's pipeline includes anti-TIGIT antibody AB154, PD-1 inhibitor zimberelima [Read more]